Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (341-350 of 365) with videos related to

Pageof 37
Sort By:
Annals of Neurology|January 26, 2026
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 YearsRodrigo Cánovas, Timothy Cox, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 11, 2026
AI-enhanced Centiloid quantification of amyloid PET imagesPierrick Bourgeat, Jurgen Fripp, Leo Lebrat, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort StudiesRalph N Martins, Victor Villemagne, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2017
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging studyKirsi M Kinnunen, David M Cash, Teresa Poole, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [<sup>11</sup>C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Nature Communications|June 6, 2022
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery diseaseGemma Cadby, Corey Giles, Phillip E Melton, et al.
Pageof 37

Showing results (341-350 of 365) with videos related to

Sort By:
Pageof 37
Annals of Neurology|January 26, 2026
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 YearsRodrigo Cánovas, Timothy Cox, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 11, 2026
AI-enhanced Centiloid quantification of amyloid PET imagesPierrick Bourgeat, Jurgen Fripp, Leo Lebrat, et al.
JAMA Neurology|September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseGemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort StudiesRalph N Martins, Victor Villemagne, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 25, 2017
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging studyKirsi M Kinnunen, David M Cash, Teresa Poole, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [<sup>11</sup>C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Nature Communications|June 6, 2022
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery diseaseGemma Cadby, Corey Giles, Phillip E Melton, et al.
Pageof 37